These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Reversible coma secondary to cefepime neurotoxicity. Abanades S; Nolla J; Rodríguez-Campello A; Pedro C; Valls A; Farré M Ann Pharmacother; 2004 Apr; 38(4):606-8. PubMed ID: 14982986 [TBL] [Abstract][Full Text] [Related]
4. The impact of cefepime as first line therapy for neutropenic fever on Clostridium difficile rates among hematology and oncology patients. Muldoon EG; Epstein L; Logvinenko T; Murray S; Doron SI; Snydman DR Anaerobe; 2013 Dec; 24():79-81. PubMed ID: 24140078 [TBL] [Abstract][Full Text] [Related]
5. Cefepime neurotoxicity: case report, pharmacokinetic considerations, and literature review. Lam S; Gomolin IH Pharmacotherapy; 2006 Aug; 26(8):1169-74. PubMed ID: 16863493 [TBL] [Abstract][Full Text] [Related]
6. Cefepime: a rare cause of encephalopathy. McNally A; Pithie A; Jardine D Intern Med J; 2012 Jun; 42(6):732-3. PubMed ID: 22697161 [No Abstract] [Full Text] [Related]
7. Cefepime-induced encephalopathy in end-stage renal disease patients. Nakagawa R; Sato K; Uesaka Y; Mitsuki T; Kondo K; Wake A; Ubara Y; Kanzaki M J Neurol Sci; 2017 May; 376():123-128. PubMed ID: 28431597 [TBL] [Abstract][Full Text] [Related]
8. Renal failure is a risk factor for cefepime-induced encephalopathy. Garces EO; Andrade de Anzambuja MF; da Silva D; Bragatti JA; Jacoby T; Saldanha Thomé F J Nephrol; 2008; 21(4):526-34. PubMed ID: 18651542 [TBL] [Abstract][Full Text] [Related]
10. Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime. Raad II; Escalante C; Hachem RY; Hanna HA; Husni R; Afif C; Boktour MR; Whimbey EE; Kontoyiannis D; Jacobson K; Kantarjian H; Levett LM; Rolston KV Cancer; 2003 Sep; 98(5):1039-47. PubMed ID: 12942573 [TBL] [Abstract][Full Text] [Related]
11. Cefepime-related encephalopathy in peritoneal dialysis patients. Lin CJ; Chen SP; Wang SJ; Fuh JL J Chin Med Assoc; 2011 Feb; 74(2):87-90. PubMed ID: 21354086 [TBL] [Abstract][Full Text] [Related]
12. Intermittent hemodialysis treatment in cefepime-induced neurotoxicity: case report, pharmacokinetic modeling, and review of the literature. Mani LY; Kissling S; Viceic D; Vogt B; Burnier M; Buclin T; Renard D Hemodial Int; 2015 Apr; 19(2):333-43. PubMed ID: 25052578 [TBL] [Abstract][Full Text] [Related]
13. The neurotoxicity and safety of treatment with cefepime in patients with renal failure. Sonck J; Laureys G; Verbeelen D Nephrol Dial Transplant; 2008 Mar; 23(3):966-70. PubMed ID: 18175786 [TBL] [Abstract][Full Text] [Related]
14. Nonconvulsive status epilepticus during cephalosporin therapy. Primavera A; Cocito L; Audenino D Neuropsychobiology; 2004; 49(4):218-22. PubMed ID: 15118360 [TBL] [Abstract][Full Text] [Related]
15. Is cefepime safe for clinical use? A Bayesian viewpoint. Kalil AC J Antimicrob Chemother; 2011 Jun; 66(6):1207-9. PubMed ID: 21471137 [TBL] [Abstract][Full Text] [Related]
16. An exploratory analysis of the ability of a cefepime trough concentration greater than 22 mg/L to predict neurotoxicity. Rhodes NJ; Kuti JL; Nicolau DP; Neely MN; Nicasio AM; Scheetz MH J Infect Chemother; 2016 Feb; 22(2):78-83. PubMed ID: 26712584 [TBL] [Abstract][Full Text] [Related]
18. Cefepime-induced neurotoxicity in a patient with coronary artery bypass. Shah M; Shah H; Maslekar A Indian J Pharmacol; 2016; 48(5):599-600. PubMed ID: 27721551 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the prevalence of convulsions associated with the use of cefepime and meropenem. Tanaka A; Takechi K; Watanabe S; Tanaka M; Suemaru K; Araki H Int J Clin Pharm; 2013 Oct; 35(5):683-7. PubMed ID: 23733559 [TBL] [Abstract][Full Text] [Related]
20. Cefepime plasma concentrations and clinical toxicity: a retrospective cohort study. Huwyler T; Lenggenhager L; Abbas M; Ing Lorenzini K; Hughes S; Huttner B; Karmime A; Uçkay I; von Dach E; Lescuyer P; Harbarth S; Huttner A Clin Microbiol Infect; 2017 Jul; 23(7):454-459. PubMed ID: 28111294 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]